KPKendra S. Plafker

Kendra S. Plafker

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Kendra S. Plafker has a total of 36 co-authors. Here are the top co-authors by number of shared publications:

  • Scott M. Plafker

    Aging and Metabolism Research Program, Oklahoma Medical Research Foundation, Oklahoma City, OK, United States

    3 shared publications
  • Abu Nasar

    Department of Cardiothoracic Surgery, Neuberger Berman Lung Cancer Research Center, New York-Presbyterian Hospital, Weill Cornell Medical College, New York, NY 10065

    1 shared publication
  • Alexandra J. Ambrico

    Cold Spring Harbor Laboratory, Cold Spring Harbor, NY

    1 shared publication
  • Brendon M. Stiles

    Department of Cardiothoracic Surgery, Neuberger Berman Lung Cancer Research Center, New York-Presbyterian Hospital, Weill Cornell Medical College, New York, NY 10065

    1 shared publication
  • Brian D. Robinson

    Department of Pathology and Laboratory Medicine, Weill Cornell Medical College, New York, USA

    1 shared publication
  • Carlos Cordon-Cardo

    Department of Pathology, Mount Sinai Medical School, New York, NY 10029

    1 shared publication

Latest Publications

  • Open Access

    Dietary protection against the visual and motor deficits induced by experimental autoimmune encephalomyelitis

    by Katarzyna Zyla-Jackson, Dorothy A. Walton, Kendra S. Plafker, Susan Kovats, Constantin Georgescu, Richard S. Brush, Madison Tytanic, Martin-Paul Agbaga, Scott M. Plafker

    Introduction: Five to eight percent of the world population currently suffers from at least one autoimmune disorder. Despite multiple immune modulatory therapies for autoimmune demyelinating diseases of the central nervous system, these treatments can be limiting for subsets of patients due to adverse effects and expense. To circumvent these barriers, we investigated a nutritional intervention in mice undergoing experimental autoimmune encephalomyelitis (EAE), a model of autoimmune-mediated demyelination that induces visual and motor pathologies similar to those experienced by people with multiple sclerosis (MS).Methods: EAE was induced in female and male mice and the impact of limiting dietary carbohydrates by feeding a ketogenic diet (KD) enriched in medium chain triglycerides (MCTs), alpha-linolenic acid (an omega-3 fatty acid), and fiber was evaluated in both a preventive regimen (prior to immunization with MOG antigen) and an interventional regimen (following the onset of symptoms). Motor scores were assigned daily and visual acuity was measured using optokinetic tracking. Immunohistochemical analyses of optic nerves were done to assess inflammatory infiltrates and myelination status. Fatty acid and cytokine profiling from blood were performed to evaluate systemic inflammatory status.Results: The KD was efficacious when fed as a preventive regimen as well as when initiated as an interventional regimen following symptom onset. The KD minimally impacted body weight during the experimental time course, increased circulating ketones, prevented motor and ocular deficits, preserved myelination of the optic nerve, and reduced infiltration of immune cells to optic nerves. The KD also increased anti-inflammatory-associated omega-3 fatty acids in the plasma and reduced select cytokines in the circulation associated with EAE-mediated pathological inflammation.Discussion: In light of ongoing clinical trials using dietary strategies to treat people with MS, these findings support that a KD enriched in MCTs, omega-3 fatty acids, and fiber promotes a systemic anti-inflammatory milieu and ameliorates autoimmune-induced demyelinating visual and motor deficits.


  • Open Access

    A PGAM5–KEAP1–Nrf2 complex is required for stress-induced mitochondrial retrograde trafficking

    by Gary B. O'Mealey, Kendra S. Plafker, William L. Berry, Ralf Janknecht, Jefferson Y. Chan, Scott M. Plafker

    The Nrf2 transcription factor is a master regulator of the cellular anti-stress response. A population of the transcription factor associates with the mitochondria through a complex with KEAP1 and the mitochondrial outer membrane histidine phosphatase, PGAM5. To determine the function of this mitochondrial complex, we knocked down each component and assessed mitochondrial morphology and distribution. We discovered that depletion of Nrf2 or PGAM5, but not KEAP1, inhibits mitochondrial retrograde trafficking induced by proteasome inhibition. Mechanistically, this disrupted motility results from aberrant degradation of Miro2, a mitochondrial GTPase that links mitochondria to microtubules. Rescue experiments demonstrate that this Miro2 degradation involves the KEAP1–cullin-3 E3 ubiquitin ligase and the proteasome. These data are consistent with a model in which an intact complex of PGAM5–KEAP1–Nrf2 preserves mitochondrial motility by suppressing dominant-negative KEAP1 activity. These data further provide a mechanistic explanation for how age-dependent declines in Nrf2 expression impact mitochondrial motility and induce functional deficits commonly linked to neurodegeneration.


  • Open Access

    The nuclear transport receptor Importin-11 is a tumor suppressor that maintains PTEN protein

    by Muhan Chen, Dawid G. Nowak, Navneet Narula, Brian Robinson, Kaitlin Watrud, Alexandra Ambrico, Tali M. Herzka, Martha E. Zeeman, Matthias Minderer, Wu Zheng, et al.

    Phosphatase and tensin homologue (PTEN) protein levels are critical for tumor suppression. However, the search for a recurrent cancer-associated gene alteration that causes PTEN degradation has remained futile. In this study, we show that Importin-11 (Ipo11) is a transport receptor for PTEN that is required to physically separate PTEN from elements of the PTEN degradation machinery. Mechanistically, we find that the E2 ubiquitin-conjugating enzyme and IPO11 cargo, UBE2E1, is a limiting factor for PTEN degradation. Using in vitro and in vivo gene-targeting methods, we show that Ipo11 loss results in degradation of Pten, lung adenocarcinoma, and neoplasia in mouse prostate with aberrantly high levels of Ube2e1 in the cytoplasm. These findings explain the correlation between loss of IPO11 and PTEN protein in human lung tumors. Furthermore, we find that IPO11 status predicts disease recurrence and progression to metastasis in patients choosing radical prostatectomy. Thus, our data introduce the IPO11 gene as a tumor-suppressor locus, which is of special importance in cancers that still retain at least one intact PTEN allele.